CGH	comparative genomic hybridization
GI	genomic index
HGSOC	high grade serous ovarian carcinoma
HRD	homologous recombination deficiency
ICI	immune checkpoint inhibitors
IHC	immunohistochemistry
ITT	intention to treat
LOH	loss of heterozygosity
LST	large-scale state transitions
OS	overall survival
PFS	progression free survival
SCNA	somatic copy number alterations
TAI	telomeric allelic imbalance
TMA	tissue microarray
TME	tumor immune microenvironment